Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Does combined therapy of curcumin and epigallocatechin gallate have a synergistic neuroprotective effect against spinal cord injury

J. Ruzicka, LM. Urdzikova, B. Svobodova, AG. Amin, K. Karova, J. Dubisova, K. Zaviskova, S. Kubinova, M. Schmidt, M. Jhanwar-Uniyal, P. Jendelova,

. 2018 ; 13 (1) : 119-127.

Language English Country India

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc18009996

Systematic inflammatory response after spinal cord injury (SCI) is one of the factors leading to lesion development and a profound degree of functional loss. Anti-inflammatory compounds, such as curcumin and epigallocatechin gallate (EGCG) are known for their neuroprotective effects. In this study, we investigated the effect of combined therapy of curcumin and EGCG in a rat model of acute SCI induced by balloon compression. Immediately after SCI, rats received curcumin, EGCG, curcumin + EGCG or saline [daily intraperitoneal doses (curcumin, 6 mg/kg; EGCG 17 mg/kg)] and weekly intramuscular doses (curcumin, 60 mg/kg; EGCG 17 mg/kg)] for 28 days. Rats were evaluated using behavioral tests (the Basso, Beattie, and Bresnahan (BBB) open-field locomotor test, flat beam test). Spinal cord tissue was analyzed using histological methods (Luxol Blue-cresyl violet staining) and immunohistochemistry (anti-glial fibrillary acidic protein, anti-growth associated protein 43). Cytokine levels (interleukin-1β, interleukin-4, interleukin-2, interleukin-6, macrophage inflammatory protein 1-alpha, and RANTES) were measured using Luminex assay. Quantitative polymerase chain reaction was performed to determine the relative expression of genes (Sort1, Fgf2, Irf5, Mrc1, Olig2, Casp3, Gap43, Gfap, Vegf, NfκB, Cntf) related to regenerative processes in injured spinal cord. We found that all treatments displayed significant behavioral recovery, with no obvious synergistic effect after combined therapy of curcumin and ECGC. Curcumin and EGCG alone or in combination increased axonal sprouting, decreased glial scar formation, and altered the levels of macrophage inflammatory protein 1-alpha, interleukin-1β, interleukin-4 and interleukin-6 cytokines. These results imply that although the expected synergistic response of this combined therapy was less obvious, aspects of tissue regeneration and immune responses in severe SCI were evident.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18009996
003      
CZ-PrNML
005      
20240703140029.0
007      
ta
008      
180404s2018 ii f 000 0|eng||
009      
AR
024    7_
$a 10.4103/1673-5374.224379 $2 doi
035    __
$a (PubMed)29451216
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ii
100    1_
$a Ruzicka, Jiri $u Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Vídenská, Prague, Czech Republic.
245    10
$a Does combined therapy of curcumin and epigallocatechin gallate have a synergistic neuroprotective effect against spinal cord injury / $c J. Ruzicka, LM. Urdzikova, B. Svobodova, AG. Amin, K. Karova, J. Dubisova, K. Zaviskova, S. Kubinova, M. Schmidt, M. Jhanwar-Uniyal, P. Jendelova,
520    9_
$a Systematic inflammatory response after spinal cord injury (SCI) is one of the factors leading to lesion development and a profound degree of functional loss. Anti-inflammatory compounds, such as curcumin and epigallocatechin gallate (EGCG) are known for their neuroprotective effects. In this study, we investigated the effect of combined therapy of curcumin and EGCG in a rat model of acute SCI induced by balloon compression. Immediately after SCI, rats received curcumin, EGCG, curcumin + EGCG or saline [daily intraperitoneal doses (curcumin, 6 mg/kg; EGCG 17 mg/kg)] and weekly intramuscular doses (curcumin, 60 mg/kg; EGCG 17 mg/kg)] for 28 days. Rats were evaluated using behavioral tests (the Basso, Beattie, and Bresnahan (BBB) open-field locomotor test, flat beam test). Spinal cord tissue was analyzed using histological methods (Luxol Blue-cresyl violet staining) and immunohistochemistry (anti-glial fibrillary acidic protein, anti-growth associated protein 43). Cytokine levels (interleukin-1β, interleukin-4, interleukin-2, interleukin-6, macrophage inflammatory protein 1-alpha, and RANTES) were measured using Luminex assay. Quantitative polymerase chain reaction was performed to determine the relative expression of genes (Sort1, Fgf2, Irf5, Mrc1, Olig2, Casp3, Gap43, Gfap, Vegf, NfκB, Cntf) related to regenerative processes in injured spinal cord. We found that all treatments displayed significant behavioral recovery, with no obvious synergistic effect after combined therapy of curcumin and ECGC. Curcumin and EGCG alone or in combination increased axonal sprouting, decreased glial scar formation, and altered the levels of macrophage inflammatory protein 1-alpha, interleukin-1β, interleukin-4 and interleukin-6 cytokines. These results imply that although the expected synergistic response of this combined therapy was less obvious, aspects of tissue regeneration and immune responses in severe SCI were evident.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Machová Urdzíková, Lucia $u Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Vídenská, Prague, Czech Republic. $7 xx0136406
700    1_
$a Svobodova, Barbora $u Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Vídeňská; Department of Neuroscience, Charles University, Second Faculty of Medicine, Prague, Czech Republic.
700    1_
$a Amin, Anubhav G $u New York Medical College, Valhalla, NY, USA.
700    1_
$a Kárová, Kristýna, $u Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Vídeňská; Department of Neuroscience, Charles University, Second Faculty of Medicine, Prague, Czech Republic. $d 1988- $7 xx0319531
700    1_
$a Dubisova, Jana $u Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Vídeňská; Department of Neuroscience, Charles University, Second Faculty of Medicine, Prague, Czech Republic.
700    1_
$a Zaviskova, Kristyna $u Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Vídeňská; Department of Neuroscience, Charles University, Second Faculty of Medicine, Prague, Czech Republic.
700    1_
$a Kubinova, Sarka $u Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Vídenská, Prague, Czech Republic.
700    1_
$a Schmidt, Meic $u New York Medical College, Valhalla, NY, USA.
700    1_
$a Jhanwar-Uniyal, Meena $u New York Medical College, Valhalla, NY, USA.
700    1_
$a Jendelova, Pavla $u Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, Vídeňská; Department of Neuroscience, Charles University, Second Faculty of Medicine, Prague, Czech Republic.
773    0_
$w MED00167287 $t Neural regeneration research $x 1673-5374 $g Roč. 13, č. 1 (2018), s. 119-127
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29451216 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180404 $b ABA008
991    __
$a 20240703140025 $b ABA008
999    __
$a ind $b bmc $g 1287481 $s 1006808
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 13 $c 1 $d 119-127 $i 1673-5374 $m Neural regeneration research $n Nerual Regen. Res. $x MED00167287
LZP    __
$a Pubmed-20180404

Find record

Citation metrics

Archiving options